SPINOSAD — all Canadian products
11 DINs
0 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is SPINOSAD, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02332493 | COMFORTIS | ELANCO CANADA LIMITED | Tablet (Chewable) | Oral | SPINOSAD 140 MG | Cancelled Post Market | |
| 02332507 | COMFORTIS | ELANCO CANADA LIMITED | Tablet (Chewable) | Oral | SPINOSAD 270 MG | Cancelled Post Market | |
| 02332515 | COMFORTIS | ELANCO CANADA LIMITED | Tablet (Chewable) | Oral | SPINOSAD 560 MG | Cancelled Post Market | |
| 02332523 | COMFORTIS | ELANCO CANADA LIMITED | Tablet (Chewable) | Oral | SPINOSAD 810 MG | Cancelled Post Market | |
| 02332531 | COMFORTIS | ELANCO CANADA LIMITED | Tablet (Chewable) | Oral | SPINOSAD 1620 MG | Cancelled Post Market | |
| 02393115 | COMFORTIS | ELANCO CANADA LIMITED | Tablet (Chewable) | Oral | SPINOSAD 90 MG | Cancelled Post Market | |
| 02375478 | TRIFEXIS | ELANCO CANADA LIMITED | Tablet (Chewable) | Oral | SPINOSAD 270 MG; MILBEMYCIN OXIME 4.5 MG | Cancelled Post Market | |
| 02375486 | TRIFEXIS | ELANCO CANADA LIMITED | Tablet (Chewable) | Oral | SPINOSAD 560 MG; MILBEMYCIN OXIME 9.3 MG | Cancelled Post Market | |
| 02375494 | TRIFEXIS | ELANCO CANADA LIMITED | Tablet (Chewable) | Oral | SPINOSAD 810 MG; MILBEMYCIN OXIME 13.5 MG | Cancelled Post Market | |
| 02375524 | TRIFEXIS | ELANCO CANADA LIMITED | Tablet (Chewable) | Oral | SPINOSAD 1620 MG; MILBEMYCIN OXIME 27 MG | Cancelled Post Market | |
| 02375451 | TRIFEXIS | ELANCO CANADA LIMITED | Tablet (Chewable) | Oral | SPINOSAD 140 MG; MILBEMYCIN OXIME 2.3 MG | Cancelled Post Market |
Browse other molecules: